Manufacturing a medical device involves more than simply extruding or injection molding parts. A completed medical device typically requires various secondary operations to function properly. Unfortunately, these additional processes (e.g. bonding, tipping, pad printing, etc.) are often overlooked when a new product is designed and moved into production—which can end up costing a company both time and money.
Packaging comprises a crucial step of the finished device manufacturing process. The packaging of a product not only protects it from environmental elements, it also acts as the face of the product and the company. So, this week we sat down with our packaging and quality teams to find out more about medical device packaging and the various solutions Biomerics has to offer.
At Biomerics, we are often asked about our vertically integrated manufacturing model. Although it’s not a novel concept—several notable companies maintain complete control of their supply chains—vertical integration is beginning to manifest itself within the medical device industry. To help our customers better understand our business model and the value that can be derived from using a contract manufacturer who is vertically integrated, we’ve created the blog post below.
SALT LAKE CITY, June 2, 2015 /PRNewswire/ — Biomerics LLC, a leading contract manufacturer and innovative polymer solutions provider for the medical device industry, announced today the launch of its proprietary Rapid-Adapt™ injection molding tool system.
Our plane has landed, our booth is set up, and we’re ready to discuss your contract manufacturing needs!
As you know, MD&M East started today and we couldn’t be more excited! Visit booth 2121 to learn more about our recently launched Rapid-Adapt™ injection molding tooling system and the many other manufacturing solutions Biomerics has to offer.
Who we are.
A few weeks ago, we briefly touched on the idea of a single-margin, one-stop-shop manufacturer compared with a broker. This week, we wanted to dive deeper into this concept and talk about the benefits that a single-margin sourcing partner can provide to the bottom line.
Before we begin discussing the advantages of a single-margin manufacturer over a broker, we need to understand the difference between the two.
Many of the medical devices found on the market today must pass rigorous sterilization testing before they can be placed into a patient’s body. With medical companies around the world increasing their focus on proper sterilization planning and testing, we decided that we would use this week to talk about sterilization management and how it plays into the design and manufacturing of a device.
This July, we’re celebrating materials month! In honor of materials month, each week we’ll be highlighting and discussing the different biomaterials (known as the Quadra™ Family of Medical Polyurethanes) and compounding capabilities that we offer to the medical device industry.
This week, to kick everything off, we’ll be talking about our most popular medical grade polyurethane line, Quadraflex™.
For our second week of materials month, we’ve chosen to highlight our most popular family of long-term implantable thermoplastic polyurethanes (TPUs); Quadrathane™.
Quadrathane™ is a line of implantable polycarbonate-based medical grade TPUs. Found in long-term devices throughout the healthcare industry, Quadrathane™ TPUs are available in both aromatic and aliphatic hard segments.
For the third week of materials month, we’ve chosen to highlight our family of extremely long-term implantable materials: Quadrasil™.
Quadrasil™ is a family of thermoplastic silicone polyurethane co-polymers that exhibit the properties of both urethane and silicone. Included in this family of materials are our standard Quadrasil™ line, Elast-Eon™, and ECSil™.
